Precot Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: June 26, 2025, 11:21 am

Competitors of Precot Ltd

All Competitor Stocks of Precot Ltd

Quarterly Result

Last Updated: May 31, 2025, 8:04 am

Below is a detailed analysis of the quarterly data for Precot Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 227.76 Cr.. The value appears strong and on an upward trend. It has increased from 211.99 Cr. (Dec 2024) to 227.76 Cr., marking an increase of 15.77 Cr..
• For Expenses, as of Mar 2025, the value is 199.63 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 185.91 Cr. (Dec 2024) to 199.63 Cr., marking an increase of 13.72 Cr..
• For Operating Profit, as of Mar 2025, the value is 28.13 Cr.. The value appears strong and on an upward trend. It has increased from 26.08 Cr. (Dec 2024) to 28.13 Cr., marking an increase of 2.05 Cr..
• For OPM %, as of Mar 2025, the value is 12.35%. The value appears strong and on an upward trend. It has increased from 12.30% (Dec 2024) to 12.35%, marking an increase of 0.05%.
• For Other Income, as of Mar 2025, the value is -11.19 Cr.. The value appears to be declining and may need further review. It has decreased from -0.42 Cr. (Dec 2024) to -11.19 Cr., marking a decrease of 10.77 Cr..
• For Interest, as of Mar 2025, the value is 4.03 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 8.04 Cr. (Dec 2024) to 4.03 Cr., marking a decrease of 4.01 Cr..
• For Depreciation, as of Mar 2025, the value is 5.35 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.44 Cr. (Dec 2024) to 5.35 Cr., marking an increase of 0.91 Cr..
• For Profit before tax, as of Mar 2025, the value is 7.56 Cr.. The value appears to be declining and may need further review. It has decreased from 13.18 Cr. (Dec 2024) to 7.56 Cr., marking a decrease of 5.62 Cr..
• For Tax %, as of Mar 2025, the value is 50.53%. The value appears to be increasing, which may not be favorable. It has increased from 29.89% (Dec 2024) to 50.53%, marking an increase of 20.64%.
• For Net Profit, as of Mar 2025, the value is 3.74 Cr.. The value appears to be declining and may need further review. It has decreased from 9.23 Cr. (Dec 2024) to 3.74 Cr., marking a decrease of 5.49 Cr..
• For EPS in Rs, as of Mar 2025, the value is 3.12. The value appears to be declining and may need further review. It has decreased from 7.69 (Dec 2024) to 3.12, marking a decrease of 4.57.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 4:25 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 11:30 am

Below is a detailed analysis of the balance sheet data for Precot Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 12.00 Cr..
• For Reserves, as of Mar 2025, the value is 436.00 Cr.. The value appears strong and on an upward trend. It has increased from 406.00 Cr. (Mar 2024) to 436.00 Cr., marking an increase of 30.00 Cr..
• For Borrowings, as of Mar 2025, the value is 329.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 373.00 Cr. (Mar 2024) to 329.00 Cr., marking a decrease of 44.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 161.00 Cr.. The value appears to be improving (decreasing). It has decreased from 163.00 Cr. (Mar 2024) to 161.00 Cr., marking a decrease of 2.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 939.00 Cr.. The value appears to be improving (decreasing). It has decreased from 954.00 Cr. (Mar 2024) to 939.00 Cr., marking a decrease of 15.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 514.00 Cr.. The value appears strong and on an upward trend. It has increased from 449.00 Cr. (Mar 2024) to 514.00 Cr., marking an increase of 65.00 Cr..
• For CWIP, as of Mar 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 56.00 Cr. (Mar 2024) to 3.00 Cr., marking a decrease of 53.00 Cr..
• For Investments, as of Mar 2025, the value is 11.00 Cr.. The value appears to be declining and may need further review. It has decreased from 15.00 Cr. (Mar 2024) to 11.00 Cr., marking a decrease of 4.00 Cr..
• For Other Assets, as of Mar 2025, the value is 411.00 Cr.. The value appears to be declining and may need further review. It has decreased from 434.00 Cr. (Mar 2024) to 411.00 Cr., marking a decrease of 23.00 Cr..
• For Total Assets, as of Mar 2025, the value is 939.00 Cr.. The value appears to be declining and may need further review. It has decreased from 954.00 Cr. (Mar 2024) to 939.00 Cr., marking a decrease of 15.00 Cr..

Notably, the Reserves (436.00 Cr.) exceed the Borrowings (329.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Precot Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 27.41. This value is within the healthy range. It has increased from 13.99 (Mar 24) to 27.41, marking an increase of 13.42.
• For Diluted EPS (Rs.), as of Mar 25, the value is 27.41. This value is within the healthy range. It has increased from 13.99 (Mar 24) to 27.41, marking an increase of 13.42.
• For Cash EPS (Rs.), as of Mar 25, the value is 42.95. This value is within the healthy range. It has increased from 32.88 (Mar 24) to 42.95, marking an increase of 10.07.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 373.75. It has increased from 348.51 (Mar 24) to 373.75, marking an increase of 25.24.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 373.75. It has increased from 348.51 (Mar 24) to 373.75, marking an increase of 25.24.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 723.49. It has decreased from 814.80 (Mar 24) to 723.49, marking a decrease of 91.31.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 96.04. This value is within the healthy range. It has increased from 60.91 (Mar 24) to 96.04, marking an increase of 35.13.
• For PBIT / Share (Rs.), as of Mar 25, the value is 80.50. This value is within the healthy range. It has increased from 42.01 (Mar 24) to 80.50, marking an increase of 38.49.
• For PBT / Share (Rs.), as of Mar 25, the value is 56.59. This value is within the healthy range. It has increased from 14.41 (Mar 24) to 56.59, marking an increase of 42.18.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 27.41. This value is within the healthy range. It has increased from 13.98 (Mar 24) to 27.41, marking an increase of 13.43.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 27.41. This value is within the healthy range. It has increased from 13.98 (Mar 24) to 27.41, marking an increase of 13.43.
• For PBDIT Margin (%), as of Mar 25, the value is 13.27. This value is within the healthy range. It has increased from 7.47 (Mar 24) to 13.27, marking an increase of 5.80.
• For PBIT Margin (%), as of Mar 25, the value is 11.12. This value is within the healthy range. It has increased from 5.15 (Mar 24) to 11.12, marking an increase of 5.97.
• For PBT Margin (%), as of Mar 25, the value is 7.82. This value is below the healthy minimum of 10. It has increased from 1.76 (Mar 24) to 7.82, marking an increase of 6.06.
• For Net Profit Margin (%), as of Mar 25, the value is 3.78. This value is below the healthy minimum of 5. It has increased from 1.71 (Mar 24) to 3.78, marking an increase of 2.07.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 3.78. This value is below the healthy minimum of 8. It has increased from 1.71 (Mar 24) to 3.78, marking an increase of 2.07.
• For Return on Networth / Equity (%), as of Mar 25, the value is 7.33. This value is below the healthy minimum of 15. It has increased from 4.01 (Mar 24) to 7.33, marking an increase of 3.32.
• For Return on Capital Employeed (%), as of Mar 25, the value is 16.97. This value is within the healthy range. It has increased from 8.67 (Mar 24) to 16.97, marking an increase of 8.30.
• For Return On Assets (%), as of Mar 25, the value is 3.50. This value is below the healthy minimum of 5. It has increased from 1.75 (Mar 24) to 3.50, marking an increase of 1.75.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.22. This value is within the healthy range. It has decreased from 0.34 (Mar 24) to 0.22, marking a decrease of 0.12.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.72. This value is within the healthy range. It has decreased from 0.88 (Mar 24) to 0.72, marking a decrease of 0.16.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.91. It has decreased from 1.05 (Mar 24) to 0.91, marking a decrease of 0.14.
• For Current Ratio (X), as of Mar 25, the value is 1.06. This value is below the healthy minimum of 1.5. It has decreased from 1.13 (Mar 24) to 1.06, marking a decrease of 0.07.
• For Quick Ratio (X), as of Mar 25, the value is 0.48. This value is below the healthy minimum of 1. It has decreased from 0.50 (Mar 24) to 0.48, marking a decrease of 0.02.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.17. This value is below the healthy minimum of 4. It has decreased from 2.39 (Mar 24) to 2.17, marking a decrease of 0.22.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 4.02. This value is within the healthy range. It has increased from 1.86 (Mar 24) to 4.02, marking an increase of 2.16.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.80. This value is below the healthy minimum of 3. It has increased from 1.27 (Mar 24) to 2.80, marking an increase of 1.53.
• For Enterprise Value (Cr.), as of Mar 25, the value is 463.04. It has decreased from 504.50 (Mar 24) to 463.04, marking a decrease of 41.46.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.53. This value is below the healthy minimum of 1. It has increased from 0.51 (Mar 24) to 0.53, marking an increase of 0.02.
• For EV / EBITDA (X), as of Mar 25, the value is 4.02. This value is below the healthy minimum of 5. It has decreased from 6.90 (Mar 24) to 4.02, marking a decrease of 2.88.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.16. This value is below the healthy minimum of 1. It has increased from 0.14 (Mar 24) to 0.16, marking an increase of 0.02.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Price / BV (X), as of Mar 25, the value is 0.31. This value is below the healthy minimum of 1. It has decreased from 0.34 (Mar 24) to 0.31, marking a decrease of 0.03.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.16. This value is below the healthy minimum of 1. It has increased from 0.14 (Mar 24) to 0.16, marking an increase of 0.02.
• For EarningsYield, as of Mar 25, the value is 0.22. This value is below the healthy minimum of 5. It has increased from 0.11 (Mar 24) to 0.22, marking an increase of 0.11.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness